Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
By P. Pappas, C. Kauffman, D. Andes, C. Clancy, K. Marr, L. Ostrosky-Zeichner, A. Reboli, M. Schuster, J. Vázquez, T. Walsh and 2 more. Clinical Infectious Diseases, 2016
3,436 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Epidemiology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/32a81df25cfe286355f8b42bb1a020d93fa4673f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- A. Rhodes
- Laura Evans
- Janice L. Zimmerman
- Mitchell M. Levy
- R. Dellinger
- Mervyn Singer
- Djillali Annane
Citations in the corpus
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 (2017, background): “Empiric use of an echinocandin (anidulafungin, micafungin, or caspofungin) is preferred in most patients with severe illness, especially in those patients with septic shock, who have recently been treated with other antifungal agents, or if Candida glabrata or Candida krusei infection is suspected f”
- Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species (2017, background): “REVIEW published: 12 January 2017 doi: 10.3389/fmicb.2016.02173 Frontiers in Microbiology | www.frontiersin.org 1 January 2017 | Volume 7 | Article 2173 Edited by: Dominique Sanglard, University of Lausanne, Switzerland Reviewed by: Miguel Cacho Teixeira, Universidade de Lisboa, Portugal Siddharth K”